Prenatrix Tablet
NDC Package 59088-166-54

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Prenatrix (ferrous fumarate, folic acid) tablets is prenatrix is indicated to provide vitamins and minerals to women throughout pregnancy and during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. This formulation utilizes a tablet delivery system. Marketed by Puretek Corporation, this product is identified by NDC 59088-166.

Identification & Billing

NDC Package Code
59088-166-54
Package Description
30 TABLET in 1 BOTTLE, PLASTIC
Product Code
59088-166
11-Digit Billing Format
59088016654

Clinical Specifications

Proprietary Name
Prenatrix
Non-Proprietary Name
Ferrous Fumarate, Folic Acid
Substance Name
.alpha.-tocopherol Acetate, Dl-; Ascorbic Acid; Calcium Carbonate; Cholecalciferol; Choline Bitartrate; Chromium Nicotinate; Cyanocobalamin; Ferrous Fumarate; Folic Acid; Magnesium Oxide; Manganese Sulfate; Molybdenum; Niacinamide; Potassium Iodide; Pyridoxine Hydrochloride; Riboflavin; Selenium; Thiamine Mononitrate; Vitamin A Acetate; Zinc Oxide
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Prenatrix is indicated to provide vitamins and minerals to women throughout pregnancy and during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. Prenatrix may be beneficial in improving the nutritional status of women prior to conception.

Regulatory & Marketing

Labeler Name
Puretek Corporation
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
08-29-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59088-166-54 identifies a specific commercial package of 30 tablet in 1 bottle, plastic of Prenatrix, a human prescription drug labeled by Puretek Corporation. This tablet is formulated for oral use and contains .alpha.-tocopherol acetate, dl-; ascorbic acid; calcium carbonate; cholecalciferol; choline bitartrate; chromium nicotinate; cyanocobalamin; ferrous fumarate; folic acid; magnesium oxide; manganese sulfate; molybdenum; niacinamide; potassium iodide; pyridoxine hydrochloride; riboflavin; selenium; thiamine mononitrate; vitamin a acetate; zinc oxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Puretek Corporation on August 29, 2020. The current certification is valid through December 31, 2026.

How is this Puretek Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59088016654. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59088-166-54
11-Digit CMS (5-4-2)
59088-0166-54

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.